FemBloc
Phase 2/3- Indications
- Female permanent birth control
Company intelligence / Profile preview
DYSIS Medical’s computer-aided colposcopy system, using the proprietary "DYSISmap" technology, is CE Marked and FDA-cleared. Clinical studies—including a large US trial with 7,555 patients—demonstrated that the system detected over 40% more women with cervical disease requiring treatment compared to conventional methods. The latest generation device is the "DYSIS Ultra," which incorporates advanced imaging and patient management features[5].
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DYSIS Medical.